Liposomal sustained-release delivery systems for intravenous injection. IV. Antitumor activity of newly synthesized lipophilic 1-.BETA.-D-arabinofuranosylcytosine prodrug-bearing liposomes.
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.